Full text

Turn on search term navigation

© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

The optimized extraction process of natural matrices such as propolis that results in extracts with significant compounds has been one of the main needs of the industry. The aim of this work was to analyze the content of the active components of Brazilian red propolis extracts previously treated with ultrasound, as well as to evaluate in vitro their performance regarding antioxidant capacity and against bacteria and tumor cells. The results of the chromatographic analysis showed the influence of ultrasound treatment for higher yields of formononetin and kaempferol. However, just a higher content of these two components was not enough to interfere with higher concentrations of phenolic compounds and flavonoids among the extracts. The ten extracts obtained showed activity against two bacterial strains, and eight of them showed >70% cytotoxicity against five neoplastic cell lines. These results demonstrated the influence of ultrasound technology as a pretreatment in obtaining the ethanolic extracts of propolis, increasing the possibility of the applicability of Brazilian red propolis in different areas.

Details

Title
Evaluation of the Potential of Brazilian Red Propolis Extracts: An Analysis of the Chemical Composition and Biological Properties
Author
de Abreu Barreto, Gabriele 1   VIAFID ORCID Logo  ; Jamile Costa Cerqueira 2 ; João Henrique de Oliveira Reis 3 ; Katharine Valéria Saraiva Hodel 2 ; Letícia Amaral Gama 2 ; Jeancarlo Pereira Anjos 2   VIAFID ORCID Logo  ; Cintia Silva Minafra-Rezende 4   VIAFID ORCID Logo  ; Andrade, Luciana Nalone 5 ; Ricardo Guimarães Amaral 6   VIAFID ORCID Logo  ; Cláudia do Ó Pessoa 7 ; Maria Cláudia dos Santos Luciano 7 ; Josiane Dantas Viana Barbosa 2   VIAFID ORCID Logo  ; Marcelo Andrés Umsza-Guez 8   VIAFID ORCID Logo  ; Bruna Aparecida Souza Machado 2 

 SENAI Institute of Innovation (ISI) in Health Advanced Systems (CIMATEC ISI SAS), SENAI CIMATEC University Center, Salvador 41650-010, Brazil; Faculty of Pharmacy, Federal University of Bahia, Salvador 40170-115, Brazil 
 SENAI Institute of Innovation (ISI) in Health Advanced Systems (CIMATEC ISI SAS), SENAI CIMATEC University Center, Salvador 41650-010, Brazil 
 Faculty of Pharmacy, Federal University of Bahia, Salvador 40170-115, Brazil 
 School of Veterinary and Animal Science, Federal University of Goiás, Goiânia 40170-115, Brazil 
 Institute of Research and Technology (ITP), Tiradentes University, Aracaju 49032-490, Brazil 
 Department of Physiology, Federal University of Sergipe, São Cristóvão 49100-000, Brazil 
 Department of Physiology and Pharmacology, Drug Research and Development Center, Federal University of Ceará, Fortaleza 60430-275, Brazil 
 Department of Biotechnology, Health Science Institute, Federal University of Bahia, Salvador 40170-115, Brazil 
First page
11741
Publication year
2022
Publication date
2022
Publisher
MDPI AG
e-ISSN
20763417
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2739421948
Copyright
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.